Atara Biotherapeutics (ATRA) Preferred Stock Liabilities (2013 - 2014)
Atara Biotherapeutics' Preferred Stock Liabilities came in at $74.57 million for Q3 2014.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Preferred Stock Liabilities (2013 - 2014) Analysis & Trends
At the end of FY2013, Atara Biotherapeutics' Preferred Stock Liabilities was $61.09 million.
- Going back by year, Preferred Stock Liabilities was $4.95 million in FY2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | - |
API Access
Atara Biotherapeutics Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();